Glucocorticoids (GCs) are known to induce apoptosis in immature double positive thymocytes during their clonal selection in thymus. 1) After development, single positive mature T cells secreted from thymus are relatively resistant to GCs at physiological concentrations. 2, 3) GCs at the pharmacological level, however, can induce apoptosis in the mature T cells. 4, 5) Furthermore, T cells activated by mitogen 6) or a specific antibody 7) are more susceptible to GCs. Therefore, the administration of glycyrrhetinic acid (GA), 8) a strong inhibitor of 11b-hydroxysteroid dehydrogenase (11b-HSD), to mice increase the level of corticosterone in the blood which consecutively induced apoptosis in thymocytes. 9) However, the pharmacological effects of GA via artifactual levels of corticosterone on peripheral T cells, which are insusceptible to normal physiological concentrations, have yet to be clarified.
Organ specific distribution and molecular diversity of 11b-HSD play roles as sophisticated regulators for systemic and intracellular glucocorticoid concentrations. 10, 11) Thus, the inhibition of the type 1 enzyme in liver has resulted in higher systemic concentrations of corticosterone, 9) while the inhibition of the type 2 enzyme in kidney by magnolol has not been shown to affect systemic levels.
2) Subtype distribution of the enzymes in other organs, especially in immune tissues and cells, is still controversial. Nonetheless, since GA is a nonspecific inhibitor of the enzymes elevating both systemic and intracellular concentrations of corticosterone, systemic GA administration should be effective on apoptosis induction in mature lymphocytes residing in peripheral tissues such as in the spleen.
In this paper, we will report our observations on enzyme activities in major organs, liver and kidney, and immune tissue such as thymus and spleen after GA administration to mice. In addition, we analyzed the elevated blood concentration of corticosterone, which synchronized with the progress of apoptosis in immune cells, thymocytes and splenocytes simultaneously.
MATERIALS AND METHODS

Mice and Reagents
Male C57BL/6 mice (4 weeks of age) were obtained from Charles River (Tokyo, Japan). The animals were housed in a room apart from other colonies and were maintained with food and water available at liberty. GA was purchased from Sigma Chemical Co. (St. Louis, MO, U.S.A.), and was administered in vivo at a dose of 2.5 mg/animal as a fine suspension in olive oil (100 ml/animal) by a single i.p. injection. Control animals received the vehicle (olive oil; Wako Biochemical Co., Osaka, Japan) alone. The mice were sacrificed under ether anesthesia.
Lymphocytes Culture The mice thymuses and spleens were minced, gently pressed to release thymocytes or splenocytes in ice-cold PBS, and passed through a nylon mesh (for thymocytes, 35 mm mesh) or stainless mesh (for splenocytes, 50 mm mesh) and washed. The cell suspension was prepared for flow cytometric analysis (see below) according to the method found in our previous paper. 9) For the acquisition of the splenocyte culture with GA, the cells were suspended in ice-cold RPMI 1640 medium supplemented with 10% fetal calf serum, 100 IU/ml of penicillin, and 100 mg/ml of streptomycin. The viable cells were then counted using a trypan blue dye exclusion test, and were adjusted to 1ϫ10 6 cells/ml for culture. The cells were then placed in 24-well flat-bottom plates (Iwaki Glass Co., Tokyo, Japan) and incubated with 1ϫ10
Ϫ11
-1ϫ10
Ϫ4 M of GA for 6 h in 5% CO 2 /air at 37°C. Agarose Gel Electrophoresis of Fragmented DNA The extraction of thymocyte and splenocyte DNA and gel electrophoresis were performed by the techniques similar to previous reports. 9) In brief, approximately 1ϫ10 6 cells were solubilized with 100 ml of lysis buffer (10 mM Tris-hydrochloride buffer, pH 8.0, containing 0.1 mM EDTA and 150 mM sodium chloride). The sample was centrifuged at 20000ϫg for 20 min. The supernatant was treated with 10 mg/ml RNase A and 50 mg/ml proteinase K. The sample was then extracted with an equal volume of phenol-chloroform using Glycyrrhetinic acid (GA) is known to inhibit glucocorticoid metabolism inhibiting 11b b-hydroxysteroid dehydrogenase (11b b-HSD). Moreover, GA administration to mice has been shown to affect the lymphoid organs through elevation of endogenous corticosterone concentration. The effect of GA administration on thymus has been demonstrated to show that considerable amounts of thymocytes undergo apoptosis by elevated levels of corticosterone in systemic circulation. However, the effect of GA administration on peripheral lymphocytes has remained unknown. In our current study, we demonstrated that a significant involution of spleen as well as thymus occurred within 24 h of a single administration of GA in mice. In addition, a flow cytometric analysis of the splenocytes taken from mice treated with GA showed a significant increase in the number of apoptotic cells which exhibited translocated phosphatidylserine outside the plasma membrane.
Furthermore, considerable inhibition of 11b b-HSD activity in GA-treated mice was observed in liver and spleen, resulting in a significant increase in concentration of corticosterone in the blood. These facts showed that the apoptosis of splenocytes was the result of indirect effect of GA through elevated levels of corticosterone. We confirmed this using cultured splenocytes in vitro where no apoptotic effect of GA was observed.
We concluded that GA administration induces cell death of not only thymocytes that are naive to corticosterone, but also splenocytes that are usually stable to its physiological concentrations.
DNA isolating-gel (Iwaki Glass) and was precipitated by an addition of 10 times volume of 3 M sodium acetate and equal volume of ethanol at Ϫ20°C. The DNA samples (10 ml/lane) were electrophoretically separated on 2.0% agarose gels containing 0.5 mg/ml ethidium bromide (Sigma) using a Mupid-2 (Advance Co., Tokyo, Japan). The DNA was then visualized with a UV transilluminater.
Flow Cytometric Analysis Detection of apoptotic cells and phenotype analysis were performed in the following two ways by flow cytometry. (i) Phosphatidylserine exposure: 1ϫ10 6 cells were stained with Annexin-V FITC and propidium iodide (PI) for 15 min. After staining, percentages of Annexin positive and PI negative cells were calculated.
(ii) Detection of T cell subtype: One million cells were stained with PE-conjugated anti-CD4 monoclonal antibody (0.1 ng/ 10 6 cells in 100 ml; PharMingen Co., San Diego, CA, U.S.A.) and FITC-conjugated anti-CD8a monoclonal antibody (0.1 ng/10 6 cells in 100 ml; PharMingen) as described previously.
After staining, a total of 20000 non-gated cells were analyzed using a FACSCalibur analyzer, and obtained histograms and dot plot data were calculated by CellQuest software (Becton Dickinson, Mountain View, CA, U.S.A.).
Determination of 11b b-HSD Activities in Tissue Homogenate Each 20 mg of tissues (liver, kidney, thymus and spleen) taken from the sacrificed mice 24 h after administration of GA were placed in ice-cold 0.25 M sucrose. The tissues were homogenized by sonication. 11b-HSD activities were determined with a method previously described. 12) Next, enzyme assay tubes containing 840 ml of 0.1 M Tris-hydrochloride buffer including 0.01% Triton-X (pH 8.5), 50 ml of 5 mM NADP ϩ (for detection of type 1 enzyme) or NAD ϩ (for detection of type 2 enzyme) (Sigma), and 200 ml of 0.3 mM cortisol as a substrate were incubated at 37°C. The incubation time for assaying both the liver and kidney homogenates was 30 min, and for assaying the homogenate fraction of thymus and spleen were 15 h. The enzyme reaction was terminated by the addition of 100 ml of 5% sulfuric acid. The tubes were vigorously voltexed and placed on ice for HPLC analysis.
Concentrations of cortisol and its 11-oxo metabolite, cortisone, in the incubation mixtures were used to calculate the enzymatic activity of 11b-HSD. These levels were determined by HPLC using a syringe-type extraction/injection device, Extrashot (Kusano Sci. Co., Tokyo Japan) as previously described. 13) Briefly, 5 ml of incubation mixture was loaded onto Extrashot, which was then attached to the sample-loading injector of the HPLC system. Subsequently, 130 ml of dichloromethane was injected into the system through Extrashot. The mobile phase was H 2 O/methanol/dichloromethane/n-hexane (0.1/8.0/30.0/61.9, v/v) at a flow rate of 1.5 ml/min. The ratio of the levels of cortisol and its metabolite cortisone, i.e., "cortisone concentration/cortisol concentration" was determined, and the specific 11b-HSD activity in tissue was calculated as pmol of cortisone generated/ min/mg protein.
Quantitative Analysis of Serum Corticosterone The extraction of serum corticosterone using diatomaceous earth column extraction, namely rapid flow fractionation (RFF), was performed by a procedure described in a previous report.
12) Briefly, the serum samples were spiked with 50 ng of prednisone as an internal standard was introduced into the RFF columns. The column system was treated with 7 ml of dichloromethane. The effluent was collected into a glass tube and left to evaporate to dryness. The residue was reconstituted with 15 ml of dichloromethane for injection onto the same HPLC system as described above. The HPLC was conducted with the mobile phase solvent of H 2 O/methanol/ dichloromethane/n-hexane (0.1/4.0/30.0/61.9, v/v).
Statistical Analyses Values were expressed as meansϮS.D. and compared by multiple comparison (Dunnett) or unpaired Student's t-test.
Calculated p values of less than 0.05 were considered significant.
RESULTS
GA Effects on Organ Weights
There was no significant difference in the body weight between mice injected with a single dose of GA (2.5 mg/mouse) and the vehicle-treated control mice (Table 1 ). The mice injected with GA showed a significant decrease in thymus and spleen weight 24 h after the administration as compared to the control mice given the vehicle alone (Table 1) . On the other hand, liver weight did not differ and kidney weight significantly increased through the administration of GA.
GA Induces Splenocyte Apoptosis in Vivo DNA fragmentation in the thymocytes and splenocytes that were prepared from the mice treated with the vehicle or GA were analyzed using agarose gel electrophoresis. Treatment of 2.5 mg GA in vivo resulted in an apparent fragmentation of thymocyte-and splenocyte-DNA as compared to those of the vehicle-treated control 24 h after the treatment (Fig. 1) . The number of both thymocytes and splenocytes were decreased by in vivo treatment of GA as compared with the control group (pϽ0.01 and pϽ0.05 respectively; Table 2 ). The decrease in the number of thymocytes by GA administration has been reported to be due to an increase in the apoptosis of thymocytes. 9) Then, apoptotic splenocytes from the mice treated with GA were examined by flow cytometry. An increase in the percentages of apoptotic cells (Annexin-V positive and propidium iodide negative cells) was seen after 24 h of GA treatment in splenocytes. Typical dot plots of Annexin-V and propidium iodide fluorescence intensity are shown in Fig. 2 . The mean percentage of apoptotic splenocytes in the GAtreated group was 43.5Ϯ6.9%, whereas that in the corresponding control was 29.3Ϯ10.5% (Fig. 3, pϽ0.02) . Staining for CD4 and CD8 revealed that there was no marked reduction in the population of CD4
ϩ single positive cells in spleen (Table 2) . Although in vivo treatment of GA induced splenocyte apoptosis was carried out as described above, the splenocytes did not show any signs of apoptosis after 6h or 24 h of in vitro treatment with 10
Ϫ4
-10 Ϫ11 M of GA as analyzed by flow cytometry (data not shown).
Inhibition of Hepatic 11b b-HSD Activity and Consequent Increase in Serum Corticosterone Concentration in GA-Treated Mice
To assess the implication of GC metabolism in GA action, we examined the dehydrogenation activity of 11b-HSD in tissues and serum corticosterone concentrations in the mice treated with GA. Table 3 shows the inhibitory effects of GA on 11b-HSD activity in liver, kidney and thymus, which were relevant to our previous report. 9) At 24 h after the administration of GA, 11b-HSD activities of both of type 1 and type 2 in thymus increased when compared with those of the control animals (pϽ0.01), whereas inhibition of the activity in the liver (type 1) strongly persisted after 24 h of administration (pϽ0.001, Table 3 ). Splenic 11b-HSD activities (type 1 and type 2) were also significantly suppressed (pϽ0.05). In the thymus, 11b-HSD activities significantly increased in both subtypes after the 24 h of GA administration as compared with the control group (pϽ0.01). Renal (type 2) 11b-HSD activity at 24 h after the administration did not show any significant difference when compared with the control mice.
To evaluate the systemic effect of GA, we measured the serum concentration of corticosterone after the administration of GA. As shown in Fig. 4 , the mean serum corticosterone concentration in the group treated with GA was 413Ϯ109 ng/ml, which was significantly higher than that in 56 Vol. 24, No. 1 
DISCUSSION
In a previous report we demonstrated that GA induces immature thymocyte apoptosis by the elevation of systemic corticosterone level via the inhibition of corticosteroid metabolism. 9) These findings provide a hypothesis that GA enhances GC action in various organs in addition to thymus by alteration of GC metabolism. 14, 15) Therefore, it was considerable that systemic elevation of GC may impact not only thymocytes but also the peripheral lymphocyte profiles.
The current study was designed to examine whether inhibition of 11b-HSD by GA would result in the death of peripheral lymphocytes by apoptosis. To confirm the features of cell death, the GA-treated splenocytes were analyzed using agarose gel electrophoresis of DNA and flow cytometry. The fragmented DNA were detected by the treatment of GA in thymocyte and splenocyte, and the number of apoptotic cells exhibiting translocation of phosphatidylserine from the inner to outer plasma membrane significantly increased after 24 h of GA administration. We also investigated whether GA induces splenocyte apoptosis in vitro, and concluded that the apoptosis-inducing effect of GA did not originate from the direct effect of GA on the splenocytes. Our previous studies 9) support these results. We have demonstrated that GA treatment caused a dramatic number of thymocyte deaths by apoptosis in only in vivo conditions, and suggested the importance of an intervention of a steroid metabolism for induction of apoptosis by GA treatment. Interestingly, while we detected a marked reduction in the number of thymocytes expressing both CD4 and CD8 (i.e. double positive T cell) by GA administration in our previous study, 9) a phenotypic analysis of the splenocytes in the present study revealed that populations of T cell subtype were unchanged with GA. Thus, the results suggest that T cell populations were regulated by unknown homeostatic mechanisms.
Moreover, to demonstrate the implication of steroid metabolism in GA action, we measured 11b-HSD activities in various organs. Particularly in liver and spleen, 11b-HSD activities were persistently inhibited even after 24 h of GA treatment. Although 11b-HSD activity in splenocyte was inhibited by GA treatment, it could be possible to consider that inhibition of 11b-HSD may be resulted from lowered viability of splenocytes by GA. However, we demonstrated that the administration of GA resulted in a significant increase in serum corticosterone concentrations. These findings are consistent with the data of our previous report. 9) From these observations, it could be postulated that GA administration induced splenocyte apoptosis through elevation of endogenous corticosterone levels via inhibition of the GC-metabolizing enzyme 11b-HSD.
In conclusion, GA-induced splenocyte apoptosis might be due, at least in part, to inhibition of liver 11b-HSD and the subsequent increase in the systemic level of corticosterone, which results in the promotion of apoptosis of splenocytes. Thus, our data suggests that the inhibition of GC metabolism influences the immune system not only in immature T cells but also in mature peripheral lymphocytes. Therefore, this study may imply a therapeutic usefulness of GA in the treatment of GC-dependent diseases or a usefulness of the application of GA in combination with GCs in these diseases. 
